ライフサイエンスコーパス: transactivator

1 e N terminal region, constitute a functional transactivator.

2 moter for an important viral transcriptional transactivator.

3 nase activation, a classic LRP1-mediated Trk transactivator.

4 3 months after inactivation of tetracycline transactivator.

5 nsa serendipity alpha gene linked to the Tet-transactivator.

6 asing expression of genes controlled by this transactivator.

7 until the recent discovery of NLRC5/class I transactivator.

8 rus protein known primarily as a promiscuous transactivator.

9 silence the expression of ICP0, a key viral transactivator.

10 ins, makes the fusion protein a constitutive transactivator.

11 egatively regulated by ICP4, the major viral transactivator.

12 BHV-4), termed HORF1/2, was a very efficient transactivator.

13 Thus, IE1 is a positive, gene-specific transactivator.

14 d by expressing the HCMV multifunctional IE1 transactivator.

15 d also impaired nsp1beta's function as a PRF transactivator.

16 PR/Cas9 to disrupt the gene for the class II transactivator.

17 to avoid the effect of the virion-associated transactivators.

18 imulation of the spared allele by artificial transactivators.

19 tors from the primitive Cbp/p300-interacting transactivator 1 expressing (CITED1+) compartment to the

20 rotein (CBP), p300, and Cbp/p300-interacting transactivator 2 (Cited2) was increased in the amygdala

21 iated with up-regulation of the MHC class II transactivator, a key transcription factor with deacetyl

22 We show that the EBNA2 transactivator activates multiple MYC enhancers and reco

23 oth necessary and sufficient for PMA-induced transactivator activity in PAI-2-expressing U937 cells.

24 of IRF3 function was maintained even if IE62 transactivator activity was disrupted.

25 gnificantly decreased when the upstream EGFR transactivator ADAM17 was inhibited.

26 These transacting factors are the class II transactivator and 3 subunits of regulatory factor X (RF

27 Coexpression of this transactivator and combinations of guide RNAs in human c

28 r equation) models where the transcriptional transactivator and promoter toggle between inactive and

29 ntrol of the reverse tetracycline-controlled transactivator and the tetracycline operator minimal pro

30 genes, including those expressing additional transactivators and putative oncogenes, are induced in a

31 a catalytically inactive Cas9 (dCas9), VP64 transactivators and single-guide RNAs that target the La

32 ICP0 also functions as a promiscuous transactivator, and it blocks repressor complexes to ena

33 esized ORF61, as well as IE62, the major VZV transactivator, appeared within 1 h, and they were targe

34 or activity in HPCs, it is unclear how viral transactivators are expressed during reactivation.

35 s and limits the ability of Ifh1 to act as a transactivator at RP genes.

36 of small interfering RNA targeting class II transactivator attenuates major histocompatibility compl

37 esigned hp-sgRNAs can tune the activity of a transactivator based on Cas9 from Streptococcus pyogenes

38 the specific interplay between the cellular transactivator Brn-3a, the environmental smoking-related

39 n, suggesting that it might be not a typical transactivator but an architectural transcription factor

40 drives the expression of crucial lytic cycle transactivators but is silenced during latency in hemato

41 a 14-kDa viral protein that acts as a potent transactivator by binding to the transactivation-respons

42 small interfering RNA targeting of class II transactivator can reduce the capacity of human endothel

43 The master transactivator CIITA is essential to the regulation of M

44 MHC Class II expression is controlled by the transactivator CIITA.

45 y mechanisms includes repression of class-II transactivator (CIITA) and MHC-II expression in infected

46 on strategies such as inhibition of class II transactivator (CIITA) and MHC-II expression, to survive

47 x (MHC)-II and its master regulator class II transactivator (CIITA) are downregulated in CML compared

48 as defined major histocompatibility class II transactivator (CIITA) as a key factor in mediating thes

49 Class II transactivator (CIITA) has a distinct function as the ma

50 or histocompatibility complex (MHC) class II transactivator (CIITA) has antiviral activity against EB

51 The class II transactivator (CIITA) is essential for the expression o

52 Class II transactivator (CIITA) is the master regulator of MHC cl

53 Class II transactivator (CIITA) is the master regulator of the ma

54 y dependent upon the binding of the class II transactivator (CIITA) to the highly conserved promoters

55 ing on whether MHC-II genes and the class II transactivator (CIITA) were being expressed, two CTCF-de

56 ition of promoter activities of MHC class II transactivator (CIITA), IFN-gamma-activated site (GAS),

57 bition of MNV replication in vitro, class II transactivator (CIITA), interferon regulatory factor 3 (

58 An NLR protein, class II transactivator (CIITA), is a key regulator of MHC class

59 olved interactions between CTCF and class II transactivator (CIITA), the master regulator of major hi

60 show that the promoter IV (pIV) of class II transactivator (CIITA), the master regulator of MHCII ex

61 ruitment of a master regulator, the class II transactivator (CIITA), to the MHC class II promoter.

62 ith the role of CREBBP in promoting class II transactivator (CIITA)-dependent transcriptional activat

63 scription through regulation of the class II transactivator (CIITA).

64 a decrease in the expression of the class II transactivator (CIITA).IMPORTANCE Human cytomegalovirus

65 or histocompatibility complex (MHC) class II transactivator, CIITA, which binds to myogenin and inhib

66 This expression is initiated by the class II transactivator, CIITA.

67 or histocompatibility complex (MHC) class II transactivator, CIITA.

68 MHC class I transactivator (CITA), NLRC5 [nucleotide-binding domain

69 ced kinase1 (PINK1) and CBP/P300-interacting transactivator (CITED2).

70 Sp3 was a weaker transactivator compared to Sp1 in Drosophila D.mel-2 cel

71 rdial cells were higher in hSCF/tetracycline transactivator compared with wild-type mice 3 days post

72 biquitin prevents destabilization of the DNA-transactivator complex by the ATPases of the 26S proteas

73 ription activator (RTA), a major lytic cycle transactivator, contributes to the development of KSHV l

74 hibits promoter function of the HLA class II transactivator, decreasing expression of genes controlle

75 including Stat-3, beta-catenin, and class II transactivator-dependent antigen presentation.

76 the IE1 and IE2 proteins, known to be strong transactivators, did not.

77 studies have suggested that RBP-Jk-dependent transactivators do not function identically.

78 The viral transactivator EBNA2 is required for this switch from Wp

79 esses MMP-1 expression by competing with MMP transactivator, Ets-1 for its coactivator p300.

80 Tet-regulated miR30-shRNA technology, robust transactivator expression and two fluorescent reporters

81 rescence-based quantification of reverse tet-transactivator expression.

82 can be rescued by reintroduction of class II transactivator expression.

83 The phosphatase and transactivator EYA family proteins are overexpressed in

84 e demonstrating that hnRNP K is an important transactivator for human LDLR gene transcription.

85 STAT1 is an activator of CIITA, the class II transactivator for MHC II expression; CIITA expression w

86 ic patch of ubiquitin as required to protect transactivators from destabilization by the proteasomal

87 s their own transcription by suppressing the transactivator function of the CLOCK:BMAL1 heterodimer d

88 For the Sacchromyces cerevisiae transactivator, GAL4, attachment of mono-ubiquitin preve

89 The MHC class II transactivator gene (CIITA) is an important transcriptio

90 pig transgenic for a mutant (human) class II transactivator gene, resulting in down-regulation of swi

91 was assessed by expression of p63, the IRF6-transactivator gene.

92 or, the mammalian Grainyhead-like epithelial transactivator (Get1/Grhl3), is important for epidermal

93 strate that co-expression of TET1 and a VP64 transactivator have a synergistic effect on the reactiva

94 n overdose because of suppression of its key transactivators, hepatocyte nuclear factor (HNF)-4alpha

95 on analysis for gene transcripts of class II transactivator, HLA-DRagr;, and HLA-DRbeta1 showed maxim

96 Since herpes simplex virus type 1 transactivator ICP0 and human cytomegalovirus transactiv

97 d antisense to the viral transcript encoding transactivator ICP0.

98 -kappaB activation and is independent of the transactivator ICP27.

99 The varicella-zoster virus major transactivator, IE62, contains a potent N-terminal acidi

100 The varicella-zoster virus (VZV) major transactivator, IE62, is involved in the expression of a

101 dentified as being the major immediate-early transactivator, IE62.

102 f the SAGA transcription complex, and the RP transactivator Ifh1 as highly acetylated nonhistone spec

103 activity of the human cytomegalovirus (HCMV) transactivator immediate early 2 (IE2).

104 tion, we have used the light-inducible GAVPO transactivator in combination with two genetically encod

105 s illustrate critical roles of NLRC5/class I transactivator in MHC class I gene regulation and host d

106 Re-expressing the class II transactivator in the PELs increased expression of downs

107 oter, as well as by the actions of different transactivators, including RUNX2.

108 -cell lymphotropic virus type I (HTLV-1) Tax transactivator initiates transformation in adult T-cell

109 d a podocyte-specific, doxycycline-inducible transactivator into a murine embryonic stem cell line wi

110 Mono-ubiquitylation of a transactivator is known to promote transcriptional activ

111 691-amino-acid (aa) KSHV Rta transcriptional transactivator is necessary and sufficient to reactivate

112 The Egr2/Krox20 transactivator is required for activation of many myelin

113 udes positive feedback activation of the Tat transactivator, it lacks ultrasensitivity.

114 HLA-II downregulation by class II transactivator knockout did not affect the extent of ros

115 different tet-transactivator/reversible tet-transactivator lines supports broad functionality of tet

116 e promotion of silencer degradation by viral transactivators may be a common mechanism for regulating

117 Transactivator-mediated cytotoxicity depends on DNA bind

118 Although FosB is likely to be involved in transactivator-mediated derepression of PAI-2 transcript

119 c adiponectin-reverse tetracycline-dependent transactivator mice (Adipo-VD) to stimulate adipose tiss

120 n the peri-infarct area of hSCF/tetracycline transactivator mice compared with wild-type mice 5 days

121 sing the responder animals with tetracycline transactivator mice under conditions in which substantia

122 Amyloid precursor protein/tetracycline transactivator mice underwent behavioral testing at 3, 6

123 -specific hSCF transgenic (hSCF/tetracycline transactivator) mice were subjected to MI.

124 acidic protein (GFAP) promoter-tetracycline transactivator mouse line with tetracycline operon-domin

125 ass I (MHC-I) transcription by disabling the transactivator NF-kappaB (p50/p65).

126 ncer cells through upregulation of the MHC-I transactivator NLRC5.

127 ur results thus identify Hgf as an important transactivator of canonical Wnt signaling that is mediat

128 e assays indicate that KLF9 itself is a weak transactivator of CYP2D6 promoter but significantly enha

129 IP4), formin-binding protein-17 (FBP-17) and transactivator of cytoskeletal assembly-1 (Toca-1), and

130 ADAM17 has been proposed to play a role as a transactivator of epidermal growth factor receptor (EGFR

131 e hypothesis that Mesp1 is a direct upstream transactivator of Etv2 during embryogenesis and that Cre

132 These results identify KLF5 as a transactivator of HIF-1alpha and show that LPA regulates

133 The findings indicate that YY1 is a potent transactivator of HTLV-1 gene expression acting via bind

134 R-138, represses expression of ICP0, a viral transactivator of lytic gene expression.

135 examination and the importance of NLRC5 as a transactivator of major histocompatibility complex (MHC)

136 ng 5 (NLRC5), a recently identified specific transactivator of major histocompatibility complex class

137 TA) encoded by the gene Orf50 RTA is a known transactivator of multiple viral genes, allowing it to c

138 knowledge, that a protein can function as a transactivator of ribosomal frameshifting.

139 nuclear MT1-MMP as a previously unsuspected transactivator of signaling networks central to macropha

140 ous nuclear ribonucleoprotein (hnRNP) K is a transactivator of Th transcription.

141 gulates DNMT1 indirectly by targeting Sp1, a transactivator of the DNMT1 gene.

142 Klf6 acts as a gp130-sensitive transactivator of the nuclear import factor importin-alp

143 mmunodeficiency virus group specific antigen/transactivator of transcription (SIV(mac239Gag/Tat)).

144 The interaction of the HIV-1 protein transactivator of transcription (Tat) and its cognate tr

145 iption factors include NF-kappaB and the HIV transactivator of transcription (Tat) as well as the cyc

146 L deficient mice, we now reveal that the HIV transactivator of transcription (Tat) can induce BBB per

147 ion protein (TAT-SNAP-23) containing the HIV transactivator of transcription (TAT) cell-penetrating s

148 The HIV-1 protein transactivator of transcription (Tat) disrupts synaptic

149 ses in intracellular Ca(2+) level upon HIV-1 transactivator of transcription (Tat) exposure.

150 culture model, we show that the HIV protein transactivator of transcription (Tat) initially potentia

151 HIV-1 transactivator of transcription (TAT) is an arginine-ric

152 neutralizing mAb against extracellular HIV-1 transactivator of transcription (Tat) is important for t

153 HIV transactivator of transcription (Tat) is released from i

154 yte function, we evaluated the impact of HIV transactivator of transcription (Tat) on Wnt/beta-cateni

155 A transactivator of transcription (TAT) peptide strategy w

156 A peptide of CRMP-2 fused to the HIV transactivator of transcription (TAT) protein (TAT-CBD3)

157 ism(s) by which viral proteins such as HIV-1 Transactivator of Transcription (Tat) protein can activa

158 Because HIV-1 Transactivator of Transcription (Tat) protein continues

159 HIV-1 transactivator of transcription (Tat) protein has been s

160 We find that the HIV transactivator of transcription (Tat) protein manipulate

161 Human immunodeficiency virus type 1 (HIV-1) transactivator of transcription (Tat) protein possesses

162 hondria would repair the defect, we used the transactivator of transcription (TAT) protein transducti

163 the signaling and neuroprotective effect of transactivator of transcription (TAT) protein transducti

164 sion in transgenic mice expressing the HIV-1 transactivator of transcription (Tat) protein.

165 ter (DAT) is the target of cocaine and HIV-1 transactivator of transcription (Tat) protein.

166 neurotoxic factors such as the viral protein transactivator of transcription (Tat) that potentiate NM

167 ein-driven, doxycycline-inducible HIV type-1 transactivator of transcription (Tat) transgenic mouse m

168 Here, we investigated the effects of HIV-1 transactivator of transcription (Tat), a protein release

169 Surprisingly, transactivator of transcription (Tat), an early virus-en

170 The HIV-1 transactivator of transcription (Tat), combined with fib

171 HIV Tat protein, which is the transactivator of transcription (Tat), plays a key role

172 To examine events triggering combined transactivator of transcription (Tat)- and morphine-indu

173 Here, we expressed transactivator of transcription (TAT)-fused proteins, So

174 e the expression and purification of various transactivator of transcription (TAT)-MeCP2 variants and

175 y conjugated to the cell-penetrating peptide transactivator of transcription (TAT).

176 leased neurotoxins such as the HIV-1 protein transactivator of transcription (Tat).

177 t infect neurons, but viral proteins such as transactivator of transcription and glycoprotein 120, or

178 In vitro, the HIV-1 regulatory protein transactivator of transcription induces SOCS3 in human a

179 studies, co-exposure with morphine enhanced transactivator of transcription neurotoxicity towards cu

180 Synergistic effects of morphine on transactivator of transcription neurotoxicity were great

181 Similar morphine-transactivator of transcription synergy was also observe

182 Here, we use NPs functionalized with TAT (transactivator of transcription) peptide (T-NPs) as an e

183 s of its cyclin T1 subunit with the HIV Tat (transactivator of transcription) protein and TAR (transa

184 Kinetic analysis of the HIV-1 Tat (transactivator of transcription)-positive transcription

185 ting neurotoxic interactions of morphine and transactivator of transcription, and support the emergin

186 present in the HIV-1-infected brain, such as transactivator of transcription, inhibits antiviral IFN-

187 n studies with the clade C sequence of HIV-1 transactivator of transcription, which did not cause neu

188 Morphine enhanced transactivator of transcription-induced inflammatory eff

189 Morphine co-exposure significantly enhanced transactivator of transcription-induced neuron death whe

190 VPA also inhibited HIV-1 transactivator of transcription-induced release of sCD40

191 Tat is a potent transactivator of viral gene expression required for HIV

192 ation assays indicated that AP-1 is a potent transactivator of XT-I promoter and that IL-1beta-induce

193 on receptor (AHR) and mediator 1 (MED1), two transactivators of Cyp1a2.

194 nscription factor Nkx2-5 is one of the major transactivators of the ANF gene in the developing heart.

195 MEL-18 suppressed SUMOylation of the ESR1 transactivators p53 and SP1, thereby driving ESR1 transc

196 ransactivator ICP0 and human cytomegalovirus transactivator pp71 also stimulate the degradation of ce

197 factor Tat is known for its transcriptional transactivator properties, we present evidence for an un

198 The viral transactivator protein (Tat) plays an essential role in

199 rom the human immunodeficiency virus 1 (HIV) transactivator protein (TAT) to mesoporous silica nanopa

200 r CCL2 that of neuroprotection against HIV-1 transactivator protein (Tat) toxicity in rat primary mid

201 tion of CD8(+) T cells, and the frequency of transactivator protein (Tax)-specific CD8(+) CTLs, thoug

202 ansporter (DAT) promoter-driven tetracycline transactivator protein (tTA), we expressed mito-PstI exc

203 e we provide evidence that hepatitis B virus transactivator protein HBx stimulates the expression of

204 Transactivator protein HBx, a major regulator of cellula

205 homomultimerization of the virus's essential transactivator protein IE2 at nuclear PML bodies.

206 osphorylation of the viral cis-E3 ligase and transactivator protein IE2 work in tandem to enable tran

207 not initiated because the tegument-delivered transactivator protein pp71 fails to enter the nucleus a

208 ORF50, the gene that encodes the major lytic transactivator protein RTA, while mLANA did not, suggest

209 with a mutation in the major immediate-early transactivator protein RTA.

210 The interaction between the HIV-1 transactivator protein Tat and TAR (transactivation resp

211 The HIV-1 transactivator protein Tat is implicated in the neuronal

212 The interaction of the HIV-1 transactivator protein Tat with its transactivation resp

213 The HTLV-1 transactivator protein Tax controls many critical cellul

214 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22

215 els of pp71 tegument protein-the major viral transactivator protein-exhibit extreme variability.

216 hrough induction of the oncogenic HTLV-1 Tax transactivator protein.

217 under the control of tetracycline-controlled transactivator protein.

218 irectly binding promoters and enhancer-bound transactivator proteins.

219 romote transcriptional activation of certain transactivator proteins.

220 ulates expression of the immediate-early EBV transactivator R.

221 ein genes requires TFIID and the DNA-binding transactivator Rap1.

222 an upstream silencer (PAUSE-1), and a distal transactivator region between -5100 and -3300, which app

223 The distal transactivator region is inducible by the phorbol ester

224 nes (RPGs) by making direct contact with the transactivator repressor activator protein 1 (Rap1).

225 x virus type 1 is an E3 ubiquitin ligase and transactivator required for the efficient switch between

226 KSHV K-RTA has been shown to be the major transactivator required for the initiation of lytic reac

227 interaction of TOE1 with the viral specific transactivator response element as part of the inhibitor

228 ette that comprises an HSP70B promoter and a transactivator-responsive promoter and (ii) transactivat

229 transactivator-responsive promoter and (ii) transactivator-responsive promoters that drive the ICP4

230 (76%) harbored mutations in the tetracycline transactivator, resulting in expression of the MYC trans

231 reover, breeding these mice to different tet-transactivator/reversible tet-transactivator lines suppo

232 transcripts and proteins of the master lytic transactivator RTA (ORF50), early lytic genes ORF57 and

233 The Epstein-Barr virus (EBV) lytic transactivator Rta activates promoters through direct bi

234 ing sequences of ORF50-encoding reactivation transactivator Rta and A6-encoding bZIP protein genes.

235 e sites now respond exclusively to the viral transactivator RTA and no longer to the host mediator IC

236 virus (KSHV) from latency requires the viral transactivator Rta to contact the host protein Jkappa re

237 early gene product of gammaHV68, replication transactivator (RTA), functions as a ubiquitin E3 ligase

238 or open reading frame 50 (ORF50)/replication transactivator (RTA)-induced activation.

239 D2))-directed reverse tetracycline-dependent transactivator (rtTA) and the tetracycline-responsive el

240 cell (PEC)-specific PEC-reverse-tetracycline transactivator (rtTA) transgenic mouse also efficiently

241 erse tetracycline-controlled transcriptional transactivator (rtTA), one with self-reporting GFP activ

242 ond cassette contains a reverse tetracycline transactivator, rtTA(M2), which directs the expression o

243 in (mVEcad) promoter for the expression of a transactivator, rtTA2S-M2; and the other driven by an in

244 ion is not well defined in terms of the host transactivator(s) required for iNOS gene expression.

245 e, which expresses a tetracycline-responsive transactivator selectively in the stratified squamous ep

246 e the expression of the reverse tetracycline transactivator (SP-C-rtTA) enabled functional analysis o

247 ter fidelity is most reliant on histone gene transactivators (Spt10, Spt21) and H3-H4 chaperones (Asf

248 cell types using the tetracycline-dependent transactivator system.

249 ess HIV transcription both through the viral transactivator Tat and via Tat-independent mechanisms.

250 f TAR's cognate protein binding partner, the transactivator Tat.

251 ansduction of human immunodeficiency virus 1-transactivator (Tat) protein and linked to the mitochond

252 ne permeabilization peptide (transcriptional transactivator, TAT).

253 urotoxic viral proteins, including the viral transactivator, tat.

254 leukemia virus (HTLV) type 1 transcriptional transactivator Tax is an oncogene sufficient to produce

255 The viral transactivator Tax is regarded as the oncoprotein respon

256 sers, and the viral genome encodes the viral transactivator Tax, which is highly homologous to the tr

257 ve up-regulation of interferon-gamma and its transactivator Tbx21/Tbet, and amelioration of autoimmun

258 tory protein-reverse tetracycline-controlled transactivator/tetracycline operator-VEGF-C double-trans

259 Using a rtTA transactivator/tetracycline promoter approach allowing i

260 development and adult life, we used an rtTA transactivator/tetracycline promoter approach that allow

261 ever, the precise mechanisms and outcomes of transactivator-TFIID interaction remain unclear.

262 The properties of XND1, a transactivator that depends on multiple linear RBR-inter

263 ICP0, a promiscuous transactivator that enhances the expression of genes int

264 The gene switch comprises (i) a transactivator that is activated by a narrow class of an

265 NA-binding proteins, we created a Cas9-based transactivator that is targeted to DNA sequences by guid

266 s from biallelic gene disruption in class II transactivator that leaves other essential properties of

267 cetylases (HDACs) because pp71, the tegument transactivator that travels to the nucleus and inactivat

268 gether, nsp1beta and one of the PCBPs act as transactivators that bind a C-rich motif near the shift

269 n of the Mpz gene is controlled by two major transactivators that coordinate Schwann cell development

270 mportant roles for the BZLF1 immediate early transactivator, the BHRF1 vBcl-2 homologue, and a novel

271 One such NLR protein is the MHC class II transactivator, the master regulator of MHC class II gen

272 ein Tax, which is believed to act as a viral transactivator through its interactions with a variety o

273 t NLRC5 acts in a manner similar to class II transactivator to drive MHC expression and revealed NLRC

274 ondary somatic mutations in the tetracycline transactivator transgene, MMTV-rtTA, rendering gene expr

275 a-myosin heavy chain reverse transcriptional transactivator transgenic mice, and the double-transgeni

276 increase dendritic development, we tested a transactivator trap assay and found that the C456S varia

277 lies in the assumption that the tetracycline transactivator (TTA) acts as an inert control element an

278 me transgene driven by the same tetracycline-TransActivator (tTA) allele, but with even higher overex

279 e that expresses the tetracycline-controlled transactivator (tTA) from the constitutively active Eef1

280 ion of the transcription factor tetracycline transactivator (tTA) or ectopic expression of a proapopt

281 ryos to drive expression of the tetracycline transactivator (tTA), the transcription factor commonly

282 he absence of tetracycline, the tetracycline transactivator (tTAV) accumulates, resulting in female d

283 ic mice carrying the tetracycline-responsive transactivator under the control of the liver activator

284 a (AML), we used a Vav promoter-tetracycline transactivator (Vav-tTA)-driven repressible TRE-NRAS(G12

285 e that the multifunctional viral translation transactivator/viroplasmin (TAV) protein from Cauliflowe

286 f SVV open reading frame 61 (ORF61), a viral transactivator, was detected most frequently in latently

287 used insulinomas transfected with the CIITA transactivator, which resulted in their expression of cl

288 the tetracycline/doxycycline-controlled Tet-transactivator, while tolerated well during development

289 Here, we test whether CBP/p300-interacting transactivator with ED-rich tail 2 (CITED2), a mechanose

290 CITED2 (CBP/p300-interacting transactivator with ED-rich tail 2) is essential for neu

291 Cited2 (CBP/p300-interacting transactivator with glutamic acid (E)/aspartic acid (D)-

292 CREB-binding protein (CBP)/p300 interacting transactivator with glutamic acid (Glu) and aspartic aci

293 Herein, we identify the CBP/p300-interacting transactivator with glutamic acid/aspartic acid-rich car

294 Cardiac CITED4 (CBP/p300-interacting transactivators with E [glutamic acid]/D [aspartic acid]

295 usly expressed in GBM cells are strong viral transactivators with oncogenic properties.

296 ctivating expression of Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domai

297 with ArsA were selected by either repressed transactivator yeast two-hybrid or reverse yeast two-hyb

298 The Epstein-Barr virus (EBV) immediate early transactivator Zta plays a key role in regulating the tr

299 olish the SUMOylation of the EBV lytic cycle transactivator ZTA was dependent on both BGLF4 SUMO bind

300 o lytic replication is governed by two viral transactivators, Zta and Rta.